Taosheng Huang*
Genomics technologies such as next-generation sequencing (NGS) and microarrays accelerate neurogenomics research by revealing the mechanisms behind complex neurological disorders such as Alzheimer’s, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and psychiatric disorders. The interaction between genetic and non-genetic mutations, epigenetics, and other factors requires an analysis of the NGS level to broaden our understanding. Arrays aids in major studies of a variety of genes related to neurological disorders. Illumina provides NGS and the same tools needed to make neurogenomics research possible.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 